Trust by Design
Building Responsible AI for India’s Healthcare Ecosystem
The biggest risk facing healthcare AI is not that it makes mistakes. The bigger risk is that people stop trusting it.
By Ramma Shiv Kumar
Artificial Intelligence is moving rapidly into healthcare.
It is supporting diagnostics, drug discovery, clinical research, hospital operations, patient engagement and public-health systems.
But healthcare is different from many other sectors.
An inaccurate recommendation can affect a diagnosis.A data breach can expose deeply personal information.A biased model can produce unequal outcomes.An unexplained AI recommendation can undermine clinical confidence.
This is why the next phase of healthcare AI cannot be defined only by accuracy, speed or productivity.
It must also be defined by trust.
For India, this becomes particularly important as we move from individual AI experiments towards population-scale adoption.
The launch of SAHI — Strategy for Artificial Intelligence in Healthcare for India — and BODH — Benchmarking Open Data Platform for Health AI — at the India AI Impact Summit 2026 is an important step in this direction. SAHI provides a national framework to promote safe, ethical, equitable and transparent adoption of AI in healthcare, while BODH provides a mechanism to benchmark health-AI models for performance, robustness, bias and generalisability.
The message is clear:
Responsible AI cannot be an afterthought.
For healthcare organisations building AI capabilities at scale, an effective AI-native GCC strategy can help embed governance, data, technology and responsible AI into the operating model from the outset.
It has to be designed into the healthcare ecosystem.
As India emerges as a global hub for healthcare GCCs, capability centers and AI-led innovation, trust will increasingly become part of India's healthcare brand. The organisations that can demonstrate responsible AI at scale may gain a significant competitive advantage in attracting global healthcare mandates.
Why This Matters for Healthcare GCCs
Healthcare GCCs are becoming the innovation engines of global pharmaceutical, med-tech and healthcare organizations, moving beyond operational support to lead AI, data and digital-transformation initiatives.
Many are already leading:
Regulatory and safety analytics
AI model development
Clinical analytics
Digital health platforms
Real-world evidence programs
Medical data management
GenAI pilots
As these capabilities move from support functions to innovation functions, GCCs will increasingly be expected to demonstrate:
Responsible AI governance
Bias management
Model validation
Data protection
Regulatory compliance
In the future, trustworthiness may become as important as technical capability when global enterprises decide where to locate healthcare AI work.
Trust Is an Operating Model, Not a Policy Document
When organisations discuss responsible AI, the conversation often starts with compliance.
Do we have the right consent?
Is the data secure?
Has the model been validated?
Who is accountable?
These questions are essential.
But responsible AI needs to go deeper.
Trust must exist across the entire AI lifecycle:
Data → Model → Validation → Deployment → Monitoring → Human Oversight
If any one of these layers fails, trust can fail.
That is why I believe healthcare organisations need to move from:
"Responsible AI as governance"
to
"Responsible AI by design."
1. Privacy Must Be Built Into the Data Architecture
Healthcare data is among the most sensitive forms of personal information.
Medical histories, diagnostic reports, genomic information, prescriptions and health behaviours cannot be treated like ordinary enterprise data.
India's Digital Personal Data Protection Rules, 2025, notified in November 2025, provide a broader framework around consent, transparency, security and responsible processing of personal data. The Rules also require clear and understandable notices describing what data is being processed and for what purpose.
For healthcare organisations, this should translate into a simple principle:
Collect what is necessary. Use it for a defined purpose. Protect it throughout its lifecycle.
AI initiatives should therefore incorporate privacy at the architecture stage—not during the final compliance review.
Techniques such as de-identification, controlled access, data minimisation and privacy-preserving approaches will become increasingly important.
2. Cybersecurity Must Become Part of Clinical Safety
As healthcare becomes increasingly digital, cybersecurity is no longer simply an IT responsibility.
It becomes part of patient safety.
Consider an AI-enabled diagnostic system.
If its underlying data is compromised, manipulated or unavailable, the consequences can extend beyond operational disruption.
Healthcare organisations therefore need to think about:
Data security
Model security
Access controls
Third-party risks
Audit trails
Incident response
Continuous monitoring
The AI security conversation must extend beyond protecting the application.
We need to protect the entire chain of trust.
3. Transparency Matters—But So Does Context
One of the most difficult questions in healthcare AI is:
"Why did the AI make this recommendation?"
The answer will not always be technically simple.
But clinicians need sufficient information to understand:
What the model is being used for
What data it considered
Where it performs reliably
Where its limitations lie
When human judgement should override it
This is where India's ICMR Ethical Guidelines for Application of Artificial Intelligence in Biomedical Research and Healthcare are important. The guidelines address ethical principles, stakeholder responsibilities, governance, ethics review and informed consent, and are intended to support responsible development, deployment and adoption of medical AI.
Explainability should therefore not mean exposing every technical detail of a model.
It should mean providing the right level of understanding for the person making the decision.
4. Validation Must Reflect India's Diversity
A model that performs well in one population may not automatically perform equally well across another.
India's healthcare environment is exceptionally diverse.
Different geographies.
Different languages.
Different socioeconomic conditions.
Different disease patterns.
Different levels of healthcare access.
This is why BODH is particularly significant.
Its purpose is to help benchmark healthcare AI models using diverse, anonymised real-world health data and assess factors including performance, robustness, bias and generalisability.
This introduces an important principle:
AI should not be considered "ready" simply because it works.
It should be considered ready when we have evidence that it works reliably for the intended context and population.
5. Human Oversight Should Remain Deliberate
The objective of healthcare AI should not be to remove humans from the decision loop.
It should be to make human decisions better.
A radiologist may use AI to identify patterns.
A doctor may use AI to synthesise a patient's history.
A researcher may use AI to explore scientific possibilities.
A regulatory professional may use AI to analyse complex information.
But accountability must remain clear.
The critical question is:
Who makes the final decision, and who is accountable for it?
Every healthcare AI deployment should have a clearly defined answer.
A Practical Example: AI-Assisted Diagnosis
Imagine an AI system supporting diabetic-retinopathy screening.
The technology may analyse retinal images and identify patients who require further clinical assessment.
A responsible AI model would not simply ask:
"Is the algorithm accurate?"
It would ask:
Was the model trained on representative data?
Has it been validated for the intended population?
Can clinicians understand its limitations?
Is patient consent appropriately managed?
Is the data securely handled?
Is there a clear escalation pathway?
What happens when the AI and clinician disagree?
Is performance continuously monitored?
That is trust by design.
The technology is only one component.
The surrounding operating model determines whether the technology can be trusted.
Trust Will Also Become a Competitive Advantage
There is an important business dimension to this conversation.
Responsible AI is often presented as a constraint on innovation.
I see it differently.
Trust can become an enabler of scale.
Patients are more likely to use digital-health services when they understand how their information is being used.
Clinicians are more likely to adopt AI when they understand its strengths and limitations.
Regulators are more likely to support innovation when evidence and accountability mechanisms exist.
Healthcare organisations are more likely to scale AI when governance is built into the operating model.
Trust therefore reduces friction.
And reduced friction enables adoption.
The Hidden Cost of Untrusted AI
Healthcare organisations that fail to establish trust may face:
Slower clinician adoption
Regulatory scrutiny
Reputation damage
Model rejection
Delayed scaling
Increased governance costs
Which means the AI initiative can fail even when the technology works.
Trust is therefore not simply an ethical requirement.
It is a business requirement.
What Should Healthcare Leaders Do Now?
I would suggest five practical actions.
1. Create a Trust-by-Design checklist
Every AI initiative should address:
Privacy + Security + Validation + Explainability + Accountability
before deployment.
2. Establish clear AI ownership
AI governance should bring together:
Clinical + Technology + Data + Legal + Ethics + Cybersecurity
rather than sitting within one function.
3. Validate for the real population
Do not rely only on vendor claims or laboratory performance.
Test models for the actual population and use case.
4. Design human oversight
Define when AI recommends, when humans decide, and what happens when the two disagree.
5. Monitor after deployment
AI governance cannot stop at launch.
Models, data and real-world conditions change.
Trust therefore requires continuous monitoring, not one-time certification.
India's Opportunity
If India can combine world-class healthcare talent, AI innovation, strong governance frameworks and responsible data practices, it has the potential to become one of the world's most trusted destinations for healthcare AI development and healthcare GCC-led innovation and responsible AI deployment.
India has an opportunity to build something much bigger than a collection of healthcare AI applications.
SAHI provides a national direction for responsible healthcare AI.
BODH creates an important benchmarking capability.
ICMR has already established ethical guidance for healthcare AI.
The DPDP framework is strengthening the foundations for responsible personal-data processing.
The next step is to connect these pieces into an ecosystem where innovation and trust grow together.
That is particularly important for India's healthcare GCCs and technology companies.
If India wants to build AI-enabled healthcare capabilities for the world, trustworthiness will be part of the product—not merely part of the compliance documentation.
From Responsible AI to Trusted AI
The healthcare AI conversation is moving quickly.
The next competitive advantage will not simply be who builds the most powerful model.
It will increasingly be who can build a model that people are willing to use, understand and trust.
That requires a different mindset.
Privacy by design.
Security by design.
Validation by design.
Human oversight by design.
Accountability by design.
This is what I mean by Trust by Design.
India has an opportunity to make responsible AI a defining feature of its healthcare ecosystem—not because regulation requires it, but because trust is ultimately what allows innovation to scale.
The question I would leave healthcare leaders with is:
As we move from AI pilots to AI at scale, are we designing systems that are merely intelligent or systems that patients, clinicians, regulators and global healthcare partners can genuinely trust?
The AI leaders of the next decade may not be the organizations that build the most sophisticated algorithms. They may be the organizations that build the highest levels of trust.
In healthcare, trust is not a feature.
Trust is the product.
That, in my view, may become India's most important competitive advantage in healthcare AI.
By Ramma Shiv Kumar
#ResponsibleAI #IndiaAI #AIinHealthcare #HealthcareAI #DigitalHealth #PatientTrust #DataPrivacy #AILeadership #HealthcareInnovation #FutureOfHealthcare
